Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cooper Collins Insider Profile
4 Followers
Cooper Collins, Director at TherapeuticsMD, holds 52.02K shares in TherapeuticsMD (Ticker: TXMD), holds 3.53M shares in Pernix Therapeutics (Ticker: PTXTQ). Most recently, Cooper Collins Bought ― shares of TherapeuticsMD on Aug 26, 2024 for an estimated value of 7.08K.
Profitable Transactions
2 out of 9 Profitable Transactions
Average Return
-47.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Cooper Collins holds in companies
Most Profitable Insider Trade
The most profitable trade made by Cooper Collins
Cooper Collins's Trading History
TherapeuticsMD
Aug 26, 2024
Director
Informative Buy
7.08K
$57.74K
Pernix Therapeutics
Apr 02, 2014
―
Uninformative Sell
472.39K
$98.74K
List of latest transactions for each holding click on a transaction to see Cooper Collins's performance on stock
You May Also Like
Cooper Collins insider profile FAQ
What is the percentage of profitable transactions made by Cooper Collins?
The percentage of profitable transactions made by Cooper Collins is 22%.
What is the average return per transaction made by Cooper Collins?
The average return per transaction made by Cooper Collins is -47.50%.
What stocks does Cooper Collins hold?
Cooper Collins holds: TXMD, PTXTQ stocks.
What was Cooper Collins’s latest transaction?
Cooper Collins latest transaction was an Informative Buy of $7.08K.
What was Cooper Collins's most profitable transaction?
Cooper Collins’s most profitable transaction was an Informative Buy of TXMD stock on June 9, 2014. The return on the trade was 87.10%.
What is Cooper Collins's role in TherapeuticsMD?
Cooper Collins's role in TherapeuticsMD is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.